SE323069B - - Google Patents
Info
- Publication number
- SE323069B SE323069B SE7282/65A SE728265A SE323069B SE 323069 B SE323069 B SE 323069B SE 7282/65 A SE7282/65 A SE 7282/65A SE 728265 A SE728265 A SE 728265A SE 323069 B SE323069 B SE 323069B
- Authority
- SE
- Sweden
- Prior art keywords
- acylates
- steroids
- hydroxymethyl
- preparation
- oxo
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 abstract 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- 239000007858 starting material Substances 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000001195 anabolic effect Effects 0.000 abstract 1
- 230000001548 androgenic effect Effects 0.000 abstract 1
- 230000001986 anti-endotoxic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- -1 chloralkyl Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940127234 oral contraceptive Drugs 0.000 abstract 1
- 239000003539 oral contraceptive agent Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 230000001072 progestational effect Effects 0.000 abstract 1
- 150000004053 quinones Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- CNIXJDVUMXTEKX-DZBHQSCQSA-N testololactone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)(OC(=O)CC4)[C@@H]4[C@@H]3CCC2=C1 CNIXJDVUMXTEKX-DZBHQSCQSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB22960/64A GB1030885A (en) | 1964-06-03 | 1964-06-03 | 6-hydroxymethyl-and 6-acyloxymethyl-3-oxo-4, 6-dienic steroids |
| GB3582764 | 1965-04-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE323069B true SE323069B (enEXAMPLES) | 1970-04-27 |
Family
ID=26256216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7282/65A SE323069B (enEXAMPLES) | 1964-06-03 | 1965-06-03 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3375167A (enEXAMPLES) |
| BE (1) | BE664925A (enEXAMPLES) |
| BR (1) | BR6570119D0 (enEXAMPLES) |
| CH (1) | CH470373A (enEXAMPLES) |
| DE (1) | DE1518555A1 (enEXAMPLES) |
| FR (1) | FR1586805A (enEXAMPLES) |
| GB (1) | GB1030885A (enEXAMPLES) |
| NL (1) | NL6507099A (enEXAMPLES) |
| SE (1) | SE323069B (enEXAMPLES) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3494943A (en) * | 1967-12-29 | 1970-02-10 | Rachelle Lab Inc | Novel 9alpha-fluoro-11beta,17alpha,21-tri-hydroxy-16-hydroxymethyl - 6-(dihydroxy) methyl-1,4-pregnadiene-3,20-diones and derivatives thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3257388A (en) * | 1960-11-10 | 1966-06-21 | Syntex Corp | 6-difluoromethyl and 6-trifluoromethyl delta-pregnadienes and the 16alpha, 17alpha acetonides thereof |
-
0
- BE BE664925D patent/BE664925A/xx unknown
-
1964
- 1964-06-03 GB GB22960/64A patent/GB1030885A/en not_active Expired
-
1965
- 1965-05-19 DE DE19651518555 patent/DE1518555A1/de active Pending
- 1965-05-20 US US457522A patent/US3375167A/en not_active Expired - Lifetime
- 1965-05-26 FR FR1586805D patent/FR1586805A/fr not_active Expired
- 1965-06-02 BR BR170119/65A patent/BR6570119D0/pt unknown
- 1965-06-03 SE SE7282/65A patent/SE323069B/xx unknown
- 1965-06-03 CH CH775465A patent/CH470373A/de not_active IP Right Cessation
- 1965-06-03 NL NL6507099A patent/NL6507099A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1586805A (enEXAMPLES) | 1970-03-06 |
| CH470373A (de) | 1969-03-31 |
| BR6570119D0 (pt) | 1973-08-02 |
| DE1518555A1 (de) | 1969-04-24 |
| BE664925A (enEXAMPLES) | |
| NL6507099A (enEXAMPLES) | 1965-12-06 |
| US3375167A (en) | 1968-03-26 |
| GB1030885A (en) | 1966-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1030885A (en) | 6-hydroxymethyl-and 6-acyloxymethyl-3-oxo-4, 6-dienic steroids | |
| US3336347A (en) | 17alpha-ethinyl-delta1, 3, 5(10)-estratriene-3, 16alpha, 17beta-triol and its estersand ethers | |
| US2861086A (en) | 17-oxygenated estra-1, 3, 5(10)-triene-1, 3-diols, and the corresponding esters and ethers | |
| US2971886A (en) | 1-dehydro-17-hydroxyprogesterone acylates and therapeutic composition thereof | |
| US3340280A (en) | Estra-4, 9-diene-3beta, 17-diols and esters thereof | |
| US3194832A (en) | 18-nor-d-homo-steroids | |
| US3691212A (en) | 17alpha-(1',3'-alkadiynyl)-17beta-acyloxy(17beta-aroyloxy) steroids | |
| US3723418A (en) | Process for the manufacture beta-hydroxy-steroid-ketones | |
| US3347880A (en) | 17alpha-halogenoethinylestranes | |
| US3510556A (en) | 17alpha-ethers of 16-methylene-19-nor-progesterones | |
| Kochakian et al. | The in vitro metabolism of 3α, 17β-androstanediol by liver and kidney | |
| Wolff et al. | Synthesis and activity of some nitro steroids | |
| US3437657A (en) | 6-fluoromethyl-3-oxo-4,6-dienic steroids and process for preparing same | |
| US3452058A (en) | 6-substituted-6-dehydro androstanes and pregnanes | |
| SE336789B (enEXAMPLES) | ||
| US3320289A (en) | 16-fluoro-androstenes and estrenes containing a 17-unsaturated halogenated hydrocarbon side chain | |
| US2838503A (en) | 6-fluoro steroids | |
| US3383282A (en) | 7alpha-methyl-3, 5-androstadiene-3, 17-diols and pharmaceutically active compositions thereof | |
| Dorfman et al. | The assay of orally administered androgens using the chick's comb | |
| US3507959A (en) | 6beta,7beta-epoxysteroids | |
| US3504003A (en) | A-nor-b-homosteroids | |
| GB1037891A (en) | Process for the manufacture of 19-nor-steroids | |
| US3459741A (en) | 1-cyclobuteno-(3',4';6alpha,7alpha) derivatives of the androstane and pregnane series | |
| GB1098283A (en) | Process for dehydrogenating a-nor-b-homo-steroids | |
| GB1225038A (en) | 4-CHLORO-1,2alpha-METHYLENE-Delta<4>,<6>-PREGNADIEN-17alpha-OL-3,20-DIONE AND ITS 17-ESTERS |